Multiple Companies Announce Spin-Offs, Earnings Dates, and Restructuring
Tap title to read story
San Diego — AnaptysBio completed the spin-off of First Tracks Biotherapeutics on April 20, 2026, transitioning to a royalty-management focus and retaining exclusive management of certain collaborations. On April 20–21, SI-BONE, Simply Good Foods, and Cytokinetics issued announcements scheduling first-quarter financial results or outlining strategic cost and leadership changes.
The immediate steps include scheduled earnings releases and investor calls: Cytokinetics set its Q1 report for May 5, 2026 with a 4:30 PM ET call; SI-BONE scheduled Q1 results for May 11, 2026 with a 4:30 PM ET call. Simply Good Foods announced cost-saving measures and leadership adjustments this week to align operations ahead of upcoming reporting.
More context
Timeline
- 1. April 20, 2026 — AnaptysBio announces completion of First Tracks Biotherapeutics spin-off.
- 2. April 20, 2026 — SI-BONE schedules first-quarter 2026 results for May 11, 2026 with a conference call.
- 3. April 21, 2026 — Simply Good Foods announces cost-saving initiatives and leadership changes.
- 4. April 21, 2026 — Cytokinetics schedules first-quarter 2026 results for May 5, 2026 with a conference call.
- 5. May 5 and May 11, 2026 — Companies will release results and hold management calls as scheduled.
Why it matters
These corporate shifts can impact your wallet. If you own stock in AnaptysBio, SI-BONE, Simply Good Foods, or Cytokinetics, keep an eye on their upcoming earnings reports. Changes in leadership or strategy can affect stock prices.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
